Inventor · disambiguated record
Frank Eldridge Lovering
Also filed as: LOVERING FRANK · LOVERING FRANK E · LOVERING FRANK ELDRIDGE
19 granted patents·7 pending applications·348 citations·filing 2000–2025
94Inventor score
Top patents by PatentIndex Score
26 records- 0197US11702424B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2020·Granted Jul 18, 2023·4 cites·8 claims
- 0297US6828344B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 7, 2004·109 cites·16 claims
- 0397US6500853B1Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2000·Granted Dec 31, 2002·104 cites·19 claims
- 0495US9879022B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2016·Granted Jan 30, 2018·19 cites·22 claims
- 0595US9458168B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2015·Granted Oct 4, 2016·17 cites·44 claims
- 0694US6916841B2Inhibitors of phospholipase enzymesINST GENETICS LLC·Filed 2002·Granted Jul 12, 2005·45 cites·28 claims
- 0791US10793579B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2019·Granted Oct 6, 2020·3 cites·8 claims
- 0890US7488832B2Azolylacylguanidines as β-secretase inhibitorsWYETH CORP·Filed 2006·Granted Feb 10, 2009·19 cites·8 claims
- 0989US7732457B2Amino-pyridines as inhibitors of β-secretaseWYETH LLC·Filed 2006·Granted Jun 8, 2010·15 cites·9 claims
- 1086US10329302B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2018·Granted Jun 25, 2019·3 cites·2 claims
- 1185US12202836B2Bicyclic-fused heteroaryl or aryl compoundsPFIZER·Filed 2023·Granted Jan 21, 2025·0 cites·14 claims
- 1285US10174000B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2016·Granted Jan 8, 2019·5 cites·10 claims
- 1383US11661419B2Benzimidazole derivative compounds and uses thereofPFIZER·Filed 2020·Granted May 30, 2023·1 cites·23 claims
- 1479US10316018B2Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulatorsPFIZER·Filed 2018·Granted Jun 11, 2019·2 cites·4 claims
- 1577US12473285B2DCN-1 modulating compounds and methods of use thereofCELLARITY INC·Filed 2024·Granted Nov 18, 2025·0 cites·30 claims
- 1671US12435087B2Modulators of DCN-1 and methods of use thereofCELLARITY INC·Filed 2024·Granted Oct 7, 2025·0 cites·27 claims
- 1763US7420001B2Biaryl sulfonamides and methods for using sameWYETH CORP·Filed 2004·Granted Sep 2, 2008·2 cites·16 claims
- 1862US2023280220A1Benzimidazole Derivative Compounds and Uses ThereofPFIZER·Filed 2023·Application pending·0 cites
- 1961US2025257063A1Dcn-1 modulating compounds and methods of use thereofCELLARITY INC·Filed 2025·Application pending·0 cites
- 2057US2024124439A1Pyrido[2,3-D]Imidazole Derivatives and Their Use As Inhibitors of ITK for the Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 2157US2024132477A1Benzimidazole Derivatives and Their Use As Inhibitors of ITK For The Treatment of Skin DiseasePFIZER·Filed 2021·Application pending·0 cites
- 2256US2008287424A1AZOLYLACYLGUANIDINES AS beta-SECRETASE INHIBITORSWYETH CORP·Filed 2008·Application pending·0 cites
- 2354US2010137298A1Biaryl Sulfonamides and Methods for Using SameWYETH CORP·Filed 2008·Application pending·0 cites
- 2445US7595327B2Beta-sulfonamide hydroxamic acid inhibitors of tace/matrix metalloproteinaseWYETH CORP·Filed 2006·Granted Sep 29, 2009·0 cites·17 claims
- 2543US2010204245A1Amino-pyridines As Inhibitors Of Beta-secretaseWYETH LLC·Filed 2010·Application pending·0 cites
- 2638US10906888B2Pyrimidine carboxamides as inhibitors of Vanin-1 enzymePFIZER·Filed 2017·Granted Feb 2, 2021·0 cites·36 claims
Join the waitlist — get patent alerts
Get an alert when Frank Eldridge Lovering files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →